Nanjing Medlander Medical Technology Co. Ltd. A (688273.SS) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China · ISIN CNE100005PV8

Price
26.95 CNY
Market cap
2.70 bn CNY
P/E (2025)
26.26
P/S (2025)
6.24
Dividend yield
2.97 %
Net margin
23.78 %
Return on equity (ROE)
7.63 %
Return on assets (ROA)
6.30 %

Nanjing Medlander Medical Technology Co. Ltd. A financials

Fiscal year20242025
Revenue424.55 m CNY431.59 m CNY
Gross profit305.51 m CNY303.00 m CNY
Operating income112.54 m CNY101.77 m CNY
EBIT126.19 m CNY107.74 m CNY
Net income101.58 m CNY102.63 m CNY
Diluted EPS – continuing operations1.02 CNY1.03 CNY

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Nanjing Medlander Medical Technology Co. Ltd. A

Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation and anti-aging product, and sports rehabilitation products, as well as consumables and IT products, such as vaginal electrodes, rectal electrodes, and vaginal probes. The company also provides electronic colposcopes, biofeedback stimulation devices, high-frequency electrocautery devices, ultrasonic uterine involution devices, and electro-ultrasound therapy devices; and finger joint rehabilitation assessment systems, portable hand function rehabilitation assessment systems, hand function magnetic stimulation systems, transcranial magnetic stimulation systems, biofeedback devices, and portable biofeedback devices. In addition, it provides pelvic floor muscle rehabilitation devices and power recliner. It serves clients in gynecology, obstetrics, rehabilitation, proctology, postpartum recovery centers, and urology areas. The company was founded in 2013 and is headquartered in Nanjing, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.